BiotechTube
Home/KinSea Lead Discovery/Anne-Kathrin Klebl
AK

Anne-Kathrin Klebl

COO

KinSea Lead Discovery

Therapeutic Areas

OncologyHematologic Cancer

KinSea Lead Discovery Pipeline

DrugIndicationPhase
Pan-mutant FLT3 InhibitorAcute Myeloid Leukemia (AML) and other hematologic tumorsPre-clinical

Leadership Team at KinSea Lead Discovery

JH
Jeanette Hammer Andersen
CEO & Co-founder
BE
Bengt Erik Haug
CSO & Co-founder
EH
Espen Holst Hansen
Scientist & Co-founder
KØ
Kine Østnes Hansen
Scientist & Co-founder
AB
Annette Bayer
Scientist & Co-founder
View full KinSea Lead Discovery profile